Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Ciprofloxacin	O
/	O
bacitracin	O
/	O
scallops	O
/	O
adhesive	O
tape	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Abdominal	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Diagnostic	O
Paracentesis	O
___	O
Ultrasound	O
guided	O
core-biopsy	O
of	O
three	O
omental	O
nodules	O
___	O
Omental	O
Biopsy	O
/	O
Paracentesis	O
___	O
History	O
of	O
Present	O
Illness:	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS:	O
Ms.	O
___	O
is	O
a	O
___	O
with	O
PMHx	O
L	O
breast	O
CA	O
s/p	O
mastectomy,	O
HTN,	O
hypothyroidism,	O
presenting	O
as	O
transfer	O
from	O
___	O
for	O
diagnostic	O
paracentesis/hepatology	O
consult	O
in	O
setting	O
of	O
new	O
ascites.	O
Patient	O
states	O
abdominal	O
pain	O
started	O
three	O
weeks	O
prior	O
to	O
admission	O
when	O
she	O
was	O
trying	O
to	O
take	O
a	O
pill	O
and	O
was	O
unable	O
to	O
swallow	O
it;	O
after	O
a	O
severe	O
choking	O
episode	O
she	O
developed	O
pain	O
in	O
her	O
right	O
flank.	O
Pain	O
gradually	O
spread	O
to	O
include	O
upper	O
abdomen	O
as	O
well.	O
She	O
was	O
seen	O
by	O
an	O
NP	O
in	O
her	O
PCP's	O
office	O
and	O
underwent	O
x-rays	O
to	O
assess	O
for	O
rib	O
fractures	O
(___)	O
and	O
a	O
CTA	O
(___)	O
for,	O
PE	O
both	O
of	O
which	O
we	O
negative	O
for	O
these	O
etiologies.	O
However,	O
the	O
CTA	O
did	O
incidentally	O
show	O
mild-to-moderate	O
nonhemorrhagic	O
ascites	O
in	O
the	O
upper	O
quadrants	O
and	O
concern	O
for	O
possible	O
peritoneal	O
carcinomatosis.	O
On	O
___	O
she	O
underwent	O
a	O
CT	O
scan	O
of	O
her	O
abdomen	O
concerning	O
for	O
findings	O
of	O
ascites	O
and	O
mesenteric	O
edema.	O
Her	O
PCP	O
instructed	O
her	O
to	O
present	O
to	O
the	O
ED	O
for	O
evaluation	O
so	O
she	O
went	O
to	O
___	O
on	O
the	O
morning	O
of	O
admission.	O
She	O
was	O
transferred	O
for	O
___	O
for	O
paracentesis	O
and	O
further	O
workup.	O
The	O
patient	O
reports	O
decreased	O
appetite	O
for	O
the	O
past	O
three	O
weeks	O
and	O
recently	O
increased	O
dyspnea	O
from	O
her	O
usual	O
baseline.	O
She	O
denies	O
fevers,	O
chill,	O
nausea,	O
vomiting,	O
confusion,	B-Delirium
blood	B-Lower_gastrointestinal_haemorrhage
in	B-Lower_gastrointestinal_haemorrhage
stool,	B-Lower_gastrointestinal_haemorrhage
diarrhea,	O
melena.	B-Upper_gastrointestinal_haemorrhage
In	O
the	O
ED:	O
Initial	O
vital	O
signs	O
were	O
notable	O
for:	O
98.5	O
80	O
110/50	O
18	O
95%	O
RA	O
Labs	O
were	O
notable	O
for:	O
-	O
Normal	O
CBC	O
-	O
Normal	O
electrolytes	O
-	O
Serum	O
albumin	O
2.9	O
-	O
Para:	O
3408	O
WBC,	O
24%	O
PMNs,	O
3%	O
Others,	O
2.9	O
albumin	O
-	O
UA	O
clean	O
Studies	O
performed	O
include:	O
___	O
RUQUS	O
1.	O
Patent	O
main	O
portal	O
vein.	O
2.	O
Small	O
volume	O
ascites.	O
3.	O
Dilated	O
common	O
bile	O
duct,	O
likely	O
following	O
cholecystectomy.	O
___	O
CXR	O
IMPRESSION:	O
No	O
acute	O
cardiopulmonary	O
process.	O
Patient	O
was	O
given:	O
___	O
16:04	O
IV	O
CefTRIAXone	O
Consults:	O
-	O
Transplant	O
surgery	O
-	O
Hepatology	O
Vitals	O
on	O
transfer:	O
98.6	O
79	O
101/62	O
18	O
94%	O
RA	O
Upon	O
arrival	O
to	O
the	O
floor,	O
patient	O
corroborates	O
above	O
HPI.	O
Additionally	O
she	O
notes	O
that	O
her	O
abdominal	O
pain	O
is	O
improved	O
from	O
3	O
weeks	O
ago.	O
She	O
has	O
noticed	O
worsening	O
SOB,	O
decreased	O
appetite,	O
increasing	O
weight,	O
and	O
a	O
larger	O
abdomen	O
over	O
the	O
past	O
3	O
weeks.	O
She	O
uses	O
2L	O
NC	O
overnight.	O
She	O
also	O
has	O
chronic	O
diarrhea.	O
Regarding	O
here	O
cancer	O
history,	O
she	O
had	O
L	O
breast	O
CA	O
s/p	O
mastectomy	O
in	O
___	O
and	O
had	O
her	O
second	O
ovary	O
removed.	O
Her	O
first	O
ovary	O
was	O
removed	O
in	O
___	O
with	O
her	O
hysterectomy	O
for	O
menorrhagia.	O
She	O
was	O
on	O
tamoxifen	O
for	O
___	O
years	O
s/p	O
breast	O
cancer	O
diagnosis.	O
Her	O
most	O
recent	O
___	O
was	O
___	O
that	O
was	O
normal	O
and	O
she	O
stopped	O
getting	O
colonoscopies	O
prior	O
to	O
___	O
and	O
has	O
a	O
history	O
of	O
polyps.	O
Past	O
Medical	O
History:	O
Hypertension	O
2L	O
O2	O
at	O
night	O
(PFTS	O
___	O
-	O
FEV1	O
2.48	O
L,	O
ratio	O
77%)	O
occasionall	O
O2	O
use	O
at	O
night	O
Bilateral	O
Knee	O
replacement	O
-	O
c/b	O
C	O
diff,	O
urinary	O
retention,	O
ileus	O
Type	O
II	O
DM-pt	O
denies	O
this	O
Nephrolithiasis	O
HFpEF	O
Cluster	O
Headache	O
Bells	O
Palsy	O
___	O
resolved	O
Retinal	O
Tear	O
-	O
___	O
Chronic	O
small	O
vessel	O
infarction	O
noted	O
MRI	O
___	O
GERD	O
s/p	O
Nissen	O
fundoplication	O
Hypothyroidism	O
L	O
Breast	O
CA	O
s/p	O
mastectomy	O
Melanoma	O
R	O
arm	O
Osteopenia	O
Hystrectomy	O
L	O
ovarian	O
cystectomy	O
Mild	O
MR	O
___	O
of	O
facial	O
bones	O
History	O
of	O
vertebral	O
fracture	O
s/p	O
CCY	O
Social	O
History:	O
___	O
Family	O
History:	O
Her	O
mother	O
died	O
at	O
age	O
___	O
of	O
rheumatic	O
heart	O
disease	O
and	O
bacterial	O
endocarditis.	O
Her	O
father	O
died	O
at	O
age	O
___	O
with	O
cerebrovascular	O
accident.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
=======================	O
VITALS:	O
97.3	O
118/75	O
92	O
18	O
94	O
RA	O
GENERAL:	O
Alert	O
and	O
interactive.	O
In	O
no	O
acute	O
distress.	O
HEENT:	O
NCAT.	O
PERRL.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
Poor	O
dentition.	O
NECK:	O
No	O
JVD.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally.	O
No	O
wheezes,	O
rhonchi	O
or	O
rales.	O
No	O
increased	O
work	O
of	O
breathing.	O
L	O
breast	O
s/p	O
mastectomy.	O
ABDOMEN:	O
Mildly	O
distended	O
and	O
TTP	O
in	O
upper	O
quadrants	O
and	O
R	O
flank.	O
Normal	O
bowels	O
sounds.	O
EXTREMITIES:	O
Trace	O
edema	O
bilaterally.	O
SKIN:	O
Warm.	O
No	O
rash.	O
NEUROLOGIC:	O
Gross	O
non-focal.	O
AOx3.	B-Delirium
DISCHARGE	O
PHYSICAL	O
EXAM	O
=======================	O
VTIALS:	O
___	O
2323	O
Temp:	O
98.1	O
PO	O
BP:	O
109/64	O
HR:	O
85	O
RR:	O
18	O
O2	O
sat:	O
90%	O
O2	O
delivery:	O
RA	O
GENERAL:	O
Alert	O
and	O
interactive.	O
In	O
no	O
acute	O
distress.	O
HEENT:	O
NCAT.	O
PERRL.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
NECK:	O
No	O
JVD.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally.	O
No	O
wheezes,	O
rhonchi	O
or	O
rales.	O
No	O
increased	O
work	O
of	O
breathing.	O
L	O
breast	O
s/p	O
mastectomy.	O
ABDOMEN:	O
Mildly	O
distended	O
and	O
TTP	O
RLQ,	O
no	O
rebound	O
or	O
guarding.	O
Normal	O
bowels	O
sounds.	O
EXTREMITIES:	O
Trace	O
edema	O
bilaterally.	O
SKIN:	O
Warm.	O
No	O
rash.	O
NEUROLOGIC:	O
CN	O
II-XII	O
grossly	O
intact,	O
no	O
focal	O
neurologic	O
deficit	O
Pertinent	O
Results:	O
LABS	O
====	O
___	O
03:55PM	O
BLOOD	O
WBC-7.7	O
RBC-4.92	O
Hgb-13.8	O
Hct-44.7	O
MCV-91	O
MCH-28.0	O
MCHC-30.9*	O
RDW-12.3	O
RDWSD-40.8	O
Plt	O
___	O
___	O
03:55PM	O
BLOOD	O
Neuts-68.8	O
Lymphs-17.1*	O
Monos-10.2	O
Eos-2.9	O
Baso-0.6	O
Im	O
___	O
AbsNeut-5.30	O
AbsLymp-1.32	O
AbsMono-0.79	O
AbsEos-0.22	O
AbsBaso-0.05	O
___	O
03:55PM	O
BLOOD	O
Plt	O
___	O
___	O
06:46AM	O
BLOOD	O
___	O
___	O
03:55PM	O
BLOOD	O
Glucose-88	O
UreaN-11	O
Creat-0.6	O
Na-138	O
K-4.3	O
Cl-105	O
HCO3-23	O
AnGap-10	O
___	O
03:55PM	O
BLOOD	O
ALT-8	O
AST-19	O
AlkPhos-47	O
TotBili-0.3	O
___	O
06:46AM	O
BLOOD	O
LD(LDH)-180	O
___	O
06:46AM	O
BLOOD	O
Lipase-16	O
___	O
06:46AM	O
BLOOD	O
CEA-7.7*	O
___	O
06:51AM	O
BLOOD	O
CA125-___*	O
___	O
03:00PM	O
BLOOD	O
CEA-7.8*	O
___:	O
CA	O
___:	O
19,	O
CA	O
___:	O
54	O
___:	O
Zinc	O
60,	O
Copper	O
121,	O
Ceruloplasmin	O
33	O
IMAGING:	O
========	O
___	O
Imaging	O
LIVER	O
OR	O
GALLBLADDER	O
US	O
IMPRESSION:	O
1.	O
Patent	O
main	O
portal	O
vein.	O
2.	O
Small	O
volume	O
ascites.	O
3.	O
Status	O
post	O
cholecystectomy.	O
Dilated	O
common	O
bile	O
duct,	O
likely	O
related	O
to	O
post	O
cholecystectomy	O
state.	O
___	O
Imaging	O
CHEST	O
(PA	O
&	O
LAT)	O
IMPRESSION:	O
No	O
acute	O
cardiopulmonary	O
process.	O
___	O
Imaging	O
US	O
INTERVENTIONAL	O
PROCE	O
IMPRESSION:	O
1.	O
Successful	O
ultrasound	O
guided	O
core-biopsy	O
of	O
omentum.	O
2.	O
Three	O
core	O
biopsy	O
samples	O
were	O
obtained	O
and	O
sent	O
for	O
pathology.	O
___	O
CXR	O
IMPRESSION:	O
Linear	O
opacities	O
in	O
the	O
right	O
midlung	O
and	O
left	O
lung	O
base	O
most	O
likely	O
represent	O
subsegmental	O
atelectasis.	O
There	O
is	O
no	O
focal	O
consolidation,	O
pleural	O
effusion	O
or	O
pneumothorax.	O
There	O
is	O
unchanged	O
cardiomegaly	O
and	O
prominence	O
of	O
the	O
central	O
pulmonary	O
vasculature.	O
No	O
pulmonary	O
edema	O
is	O
identified.	O
There	O
are	O
moderate	O
multilevel	O
degenerative	O
changes	O
of	O
the	O
thoracic	O
spine.	O
Surgical	O
clips	O
are	O
noted	O
in	O
the	O
left	O
upper	O
quadrant	O
of	O
the	O
abdomen.	O
___	O
CT	O
Chest	O
with	O
Contrast	O
IMPRESSION:	O
1.	O
Scattered	O
3-4	O
mm	O
pulmonary	O
nodules	O
are	O
unchanged	O
from	O
most	O
recent	O
prior,	O
and	O
at	O
least	O
2	O
are	O
unchanged	O
from	O
___.	O
2.	O
A	O
1.5	O
cm	O
right	O
diaphragmatic	O
lymph	O
node	O
is	O
increased	O
from	O
8	O
mm	O
in	O
___.	O
3.	O
Bilateral	O
lower	O
lobe	O
atelectasis.	O
4.	O
Ascites	O
is	O
noted	O
in	O
the	O
upper	O
abdomen.	O
___	O
US	O
Paracentesis	O
and	O
Biopsy	O
IMPRESSION:	O
1.	O
Technically	O
successful	O
ultrasound	O
guided	O
diagnostic	O
and	O
therapeutic	O
paracentesis.	O
2.	O
3	O
L	O
of	O
fluid	O
were	O
removed	O
and	O
1L	O
was	O
sent	O
for	O
requested	O
analysis.	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
PMHx	O
L	O
breast	O
CA	O
s/p	O
mastectomy,	O
HTN,	O
hypothyroidism,	O
presenting	O
as	O
transfer	O
from	O
___	O
for	O
diagnostic	O
paracentesis/hepatology	O
consult	O
in	O
setting	O
of	O
new	O
ascites	O
with	O
concern	O
for	O
possible	O
peritoneal	O
carcionomatosis	O
in	O
upper	O
quadrants	O
bilaterally.	O
Cytology	O
from	O
the	O
peritoneal	O
fluid	O
was	O
consistent	O
with	O
adenocarcinoma,	O
but	O
biopsy	O
was	O
inconclusive.	O
She	O
was	O
seen	O
by	O
hematology/oncology	O
and	O
underwent	O
a	O
repeat	O
paracentesis	O
and	O
biopsy	O
with	O
plan	O
to	O
follow	O
up	O
on	O
the	O
results	O
as	O
an	O
outpatient.	O
She	O
was	O
evaluated	O
by	O
___	O
during	O
her	O
stay	O
and	O
was	O
discharged	O
to	O
rehab	O
for	O
weakness/deconditioning.	O
ACUTE	O
ISSUES	O
============	O
#	O
Concern	O
for	O
abdominal	O
malignancy:	O
CTA	O
on	O
___	O
showed	O
peritoneal	O
carcinomatosis.	O
Biopsy	O
results	O
not	O
conclusive	O
as	O
above.	O
Cytology	O
with	O
atypical	O
cells	O
suspicious	O
for	O
adenocarcinoma.	O
She	O
underwent	O
repeat	O
omental	O
bx	O
as	O
well	O
as	O
diagnostic/therapeutic	O
paracentesis	O
on	O
the	O
day	O
of	O
discharge	O
which	O
she	O
tolerated	O
very	O
well	O
and	O
will	O
follow	O
up	O
with	O
oncology	O
as	O
outpatient.	O
#	O
Ascites:	O
Presenting	O
with	O
3	O
weeks	O
of	O
abdominal	O
pain	O
and	O
ascites.	O
Diagnostic	O
paracentesis	O
with	O
high	O
WBC	O
(3408)	O
with	O
24%	O
polys	O
(817)	O
which	O
is	O
greater	O
than	O
the	O
250	O
cutoff	O
for	O
spontaneous	O
bacterial	O
peritonitis.	O
SAAG	O
is	O
0	O
indicating	O
a	O
non-portal	O
HTN	O
related	O
etiology	O
of	O
the	O
ascites,	O
likely	O
malignancy	O
given	O
CT	O
findings	O
as	O
above.	O
She	O
was	O
treated	O
empirically	O
for	O
possible	O
SBP.	O
Ascites	O
cultures	O
negative.	O
Due	O
to	O
high	O
suspicion	O
for	O
malignant	O
effusion	O
rather	O
than	O
SBP	O
and	O
the	O
fact	O
that	O
malignant	O
effusions	O
can	O
sometimes	O
mimic	O
cell	O
counts	O
similar	O
to	O
SBP,	O
decision	O
was	O
made	O
not	O
to	O
continue	O
Bactrim	O
PPX	O
as	O
outpatient.	O
She	O
had	O
a	O
repeat	O
paracentesis	O
on	O
the	O
day	O
of	O
discharge	O
as	O
above.	O
CHRONIC	O
ISSUES	O
==============	O
#	O
Hypothyroidism:	O
She	O
was	O
continued	O
on	O
home	O
levothyroxine	O
37.5mcg	O
daily	O
#	O
HTN:	O
She	O
was	O
continued	O
on	O
home	O
metoprolol	O
succinate	O
100mg	O
daily.	O
Amlodipine	O
2.5mg	O
daily	O
was	O
initially	O
continued	O
but	O
was	O
ultimately	O
d/c'ed	O
in	O
the	O
setting	O
of	O
borderline	O
BPs.	O
#	O
Anxiety:	O
She	O
was	O
continued	O
on	O
home	O
amitriptyline	O
and	O
diazepam	O
#	O
Overactive	O
bladder:	O
She	O
was	O
continued	O
on	O
home	O
tolterodine	O
#	O
Primary	O
prevention:	O
She	O
was	O
continued	O
on	O
aspirin	O
81mg.	O
TRANSITIONAL	O
ISSUES	O
===================	O
[	O
]	O
Continue	O
to	O
monitor	O
for	O
signs	O
of	O
increasing	O
abdominal	O
pain/distension.	O
Given	O
peritoneal	O
carcinomatosis	O
may	O
need	O
repeat	O
therapeutic	O
paracentesis.	O
[	O
]	O
Patient	O
was	O
not	O
started	O
on	O
PPX	O
for	O
SBP	O
given	O
that	O
her	O
suspicion	O
of	O
SBP	O
was	O
very	O
low.	O
Her	O
exudative	O
and	O
very	O
cellular	O
ascitic	O
fluid	O
is	O
likely	O
malignant	O
in	O
nature	O
and	O
cultures	O
remained	O
negative.	O
[	O
]	O
Patient's	O
SBP	O
this	O
admission	O
was	O
intermittently	O
in	O
the	O
90-100s,	O
so	O
her	O
home	O
amlodipine	O
was	O
stopped.	O
Continue	O
to	O
monitor	O
as	O
outpatient.	O
[	O
]	O
The	O
patient	O
had	O
been	O
using	O
O2	O
at	O
night	O
at	O
home.	O
However,	O
in	O
house,	O
she	O
was	O
monitored	O
off	O
of	O
O2	O
without	O
any	O
significant	O
desaturations	O
noted.	O
Would	O
continue	O
to	O
monitor	O
and	O
consider	O
sleep	O
study	O
as	O
needed.	O
[	O
]	O
The	O
patient	O
had	O
a	O
positive	O
UCx	O
during	O
admission	O
without	O
any	O
reported	O
urinary	O
symptoms.	O
She	O
was	O
treated	O
with	O
abx	O
for	O
possible	O
SBP,	O
which	O
would	O
have	O
covered	O
potential	O
UTI	B-Urinary_tract_infection
anyway.	O
[	O
]	O
Nutritional	O
labs	O
notable	O
for	O
low	O
Vitamin	O
A	O
as	O
well	O
as	O
borderline	O
low	O
zinc.	O
Could	O
consider	O
starting	O
supplementation.	O
[	O
]	O
CEA,	O
CA-125,	O
and	O
CA	O
___	O
were	O
elevated.	O
CA	O
___	O
WNL.	O
Repeat	O
omental	O
biopsy	O
and	O
ascitic	O
fluid	O
cytology	O
were	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
and	O
will	O
need	O
to	O
be	O
followed	O
up.	O
[	O
]	O
Chest	O
CT	O
notable	O
for	O
"1.	O
Scattered	O
3-4	O
mm	O
pulmonary	O
nodules	O
are	O
unchanged	O
from	O
most	O
recent	O
prior,	O
and	O
at	O
least	O
2	O
are	O
unchanged	O
from	O
___.	O
2.	O
A	O
1.5	O
cm	O
right	O
diaphragmatic	O
lymph	O
node	O
is	O
increased	O
from	O
8	O
mm	O
in	O
___	O
#	O
CODE:	O
Full	O
#	O
CONTACT:	O
___	O
(son)	O
___	O
and	O
___	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
TraMADol	O
50	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
2.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QAM	O
3.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
4.	O
tolterodine	O
4	O
mg	O
PO	O
DAILY	O
5.	O
Diazepam	O
2.5	O
mg	O
PO	O
BID	O
6.	O
Gabapentin	O
200	O
mg	O
PO	O
QHS	O
7.	O
Levothyroxine	O
Sodium	O
37.5	O
mcg	O
PO	O
DAILY	O
8.	O
amLODIPine	O
2.5	O
mg	O
PO	O
DAILY	O
9.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
10.	O
Amitriptyline	O
25	O
mg	O
PO	O
QHS	O
11.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
12.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
DAILY	O
13.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
14.	O
biotin	O
1	O
mg	O
oral	O
DAILY	O
15.	O
Centrum	O
Silver	O
(multivit-min-FA-lycopen-lutein;<br>mv-min-folic	O
acid-lutein)	O
0.4-300-250	O
mg-mcg-mcg	O
oral	O
DAILY	O
Discharge	O
Medications:	O
1.	O
LOPERamide	O
2	O
mg	O
PO	O
DAILY:PRN	O
diarrhea	O
2.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
DAILY	O
3.	O
Amitriptyline	O
25	O
mg	O
PO	O
QHS	O
4.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
5.	O
biotin	O
1	O
mg	O
oral	O
DAILY	O
6.	O
Centrum	O
Silver	O
(multivit-min-FA-lycopen-lutein;<br>mv-min-folic	O
acid-lutein)	O
0.4-300-250	O
mg-mcg-mcg	O
oral	O
DAILY	O
7.	O
Diazepam	O
2.5	O
mg	O
PO	O
BID	O
8.	O
Gabapentin	O
200	O
mg	O
PO	O
QHS	O
9.	O
Levothyroxine	O
Sodium	O
37.5	O
mcg	O
PO	O
DAILY	O
10.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QAM	O
11.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
12.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
13.	O
tolterodine	O
4	O
mg	O
PO	O
DAILY	O
14.	O
TraMADol	O
50	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Moderate	O
15.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
16.	O
HELD-	O
amLODIPine	O
2.5	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
amLODIPine	O
until	O
you	O
are	O
told	O
to	O
restart	O
it	O
byy	O
our	O
PCP	O
___:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY:	O
========	O
Peritoneal	O
Carcinomatosis	O
SECONDARY:	O
==========	O
Hypertension	O
Hypothyroidism	O
Anxiety/Depression	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	O
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
privilege	O
caring	O
for	O
you	O
at	O
___	O
___.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
came	O
to	O
the	O
hospital	O
due	O
to	O
new	O
fluid	O
build	O
up	O
in	O
your	O
stomach.	O
WHAT	O
HAPPENED	O
TO	O
ME	O
IN	O
THE	O
HOSPITAL?	O
-	O
On	O
imaging,	O
we	O
found	O
some	O
masses	O
on	O
the	O
tissue	O
(peritoneum)	O
that	O
covers	O
some	O
of	O
the	O
organs	O
in	O
your	O
abdomen	O
as	O
well	O
as	O
fluid	O
in	O
your	O
abdomen,	O
some	O
of	O
which	O
we	O
removed.	O
-	O
Unfortunately,	O
the	O
fluid	O
under	O
the	O
microscope	O
did	O
show	O
signs	O
of	O
cancer,	O
but	O
no	O
signs	O
of	O
bacteria.	O
-	O
You	O
were	O
seen	O
by	O
the	O
oncology	O
team,	O
and	O
they	O
will	O
set	O
up	O
an	O
outpatient	O
follow-up	O
with	O
an	O
oncologist	O
in	O
___	O
for	O
you	O
to	O
continue	O
your	O
treatment.	O
-	O
We	O
started	O
you	O
on	O
IV	O
antibiotics.	O
After	O
you	O
completed	O
your	O
course	O
of	O
IV	O
antibiotics,	O
you	O
were	O
feeling	O
better,	O
and	O
it	O
was	O
thought	O
that	O
the	O
fluid	O
in	O
your	O
abdomen	O
was	O
more	O
likely	O
due	O
to	O
cancer	O
rather	O
than	O
infection,	O
so	O
your	O
oral	O
antibiotics	O
were	O
stopped.	O
-	O
You	O
had	O
a	O
repeat	O
procedure	O
to	O
remove	O
more	O
fluid	O
from	O
your	O
abdomen	O
and	O
another	O
biopsy	O
for	O
further	O
testing.	O
You	O
will	O
follow	O
up	O
these	O
results	O
with	O
your	O
oncologist.	O
WHAT	O
SHOULD	O
I	O
DO	O
AFTER	O
I	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Continue	O
to	O
take	O
all	O
your	O
medicines	O
and	O
keep	O
your	O
appointments.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

